USD 46.85
(-4.13%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 1.13 Billion USD | -15.4% |
2022 | 1.34 Billion USD | -0.99% |
2021 | 1.36 Billion USD | 60.51% |
2020 | 847.85 Million USD | 2449.49% |
2019 | 33.25 Million USD | 27846.22% |
2018 | 119 Thousand USD | -74.13% |
2017 | 460 Thousand USD | -97.28% |
2016 | 16.9 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 1.14 Billion USD | 0.06% |
2024 Q2 | 1.14 Billion USD | 0.06% |
2023 Q4 | 1.13 Billion USD | -14.42% |
2023 FY | 1.13 Billion USD | -15.4% |
2023 Q2 | 1.33 Billion USD | -0.45% |
2023 Q1 | 1.34 Billion USD | -0.34% |
2023 Q3 | 1.33 Billion USD | -0.37% |
2022 Q2 | 1.35 Billion USD | -0.24% |
2022 Q4 | 1.34 Billion USD | -0.41% |
2022 FY | 1.34 Billion USD | -0.99% |
2022 Q1 | 1.36 Billion USD | -0.0% |
2022 Q3 | 1.35 Billion USD | -0.35% |
2021 Q2 | 1.34 Billion USD | 0.16% |
2021 FY | 1.36 Billion USD | 60.51% |
2021 Q1 | 1.34 Billion USD | 58.42% |
2021 Q4 | 1.36 Billion USD | 0.73% |
2021 Q3 | 1.35 Billion USD | 0.42% |
2020 Q4 | 847.85 Million USD | 2036.63% |
2020 Q1 | 33.77 Million USD | 1.55% |
2020 Q2 | 41.11 Million USD | 21.75% |
2020 FY | 847.85 Million USD | 2449.49% |
2020 Q3 | 39.68 Million USD | -3.49% |
2019 Q4 | 33.25 Million USD | 58243.86% |
2019 Q3 | 57 Thousand USD | -28.75% |
2019 Q2 | 80 Thousand USD | -20.0% |
2019 Q1 | 100 Thousand USD | -15.97% |
2019 FY | 33.25 Million USD | 27846.22% |
2018 Q4 | 119 Thousand USD | -13.14% |
2018 FY | 119 Thousand USD | -74.13% |
2018 Q1 | - USD | -100.0% |
2018 Q2 | 154 Thousand USD | 0.0% |
2018 Q3 | 137 Thousand USD | -11.04% |
2017 Q4 | 460 Thousand USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | 460 Thousand USD | -97.28% |
2016 FY | 16.9 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aclaris Therapeutics, Inc. | 3.07 Million USD | -36984.125% |
Biodesix, Inc. | 35.22 Million USD | -3136.241% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -101822.093% |
Castle Biosciences, Inc. | 14.19 Million USD | -7929.06% |
DarioHealth Corp. | 24.59 Million USD | -4535.704% |
Exact Sciences Corporation | 2.47 Billion USD | 53.947% |
IDEXX Laboratories, Inc. | 622.88 Million USD | -83.014% |
Illumina, Inc. | 1.48 Billion USD | 23.441% |
Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -1401658.399% |
iSpecimen Inc. | 29.13 Thousand USD | -3913274.528% |
Standard BioTools Inc. | 3.98 Million USD | -28520.788% |
23andMe Holding Co. | 67.84 Million USD | -1580.251% |
Medpace Holdings, Inc. | 142.12 Million USD | -702.104% |
NeoGenomics, Inc. | 606.06 Million USD | -88.092% |
Inotiv, Inc. | 399.4 Million USD | -185.413% |
Psychemedics Corporation | 945 Thousand USD | -120531.323% |
Prenetics Global Limited | 867.21 Thousand USD | -131351.37% |
Precipio, Inc. | 106 Thousand USD | -1075339.623% |
RadNet, Inc. | 812.06 Million USD | -40.378% |
Sotera Health Company | 2.22 Billion USD | 48.735% |
Star Equity Holdings, Inc. | 1.14 Million USD | -99460.349% |
Exagen Inc. | 19.23 Million USD | -5827.752% |
Natera, Inc. | 282.94 Million USD | -302.893% |
Aspira Women's Health Inc. | 1.43 Million USD | -79617.902% |
Neogen Corporation | 888.39 Million USD | -28.318% |
Myriad Genetics, Inc. | 130.9 Million USD | -770.868% |
ICON Public Limited Company | 3.66 Billion USD | 68.9% |
Bionano Genomics, Inc. | 7.17 Million USD | -15788.028% |
CareDx, Inc | 28.27 Million USD | -3931.282% |
Check-Cap Ltd. | - USD | -Infinity% |
Twist Bioscience Corporation | 79.17 Million USD | -1339.842% |
BioNexus Gene Lab Corp. | 98.76 Thousand USD | -1154143.998% |
Fulgent Genetics, Inc. | 10.11 Million USD | -11174.513% |
Sera Prognostics, Inc. | 840 Thousand USD | -135610.238% |
OPKO Health, Inc. | 222.03 Million USD | -413.42% |
Personalis, Inc. | 1.23 Million USD | -92279.741% |
Applied DNA Sciences, Inc. | 739.16 Thousand USD | -154124.108% |
Star Equity Holdings, Inc. | 1.14 Million USD | -99460.349% |
MDxHealth SA | 35.56 Million USD | -3105.393% |
Prenetics Global Limited | 867.21 Thousand USD | -131351.37% |
ENDRA Life Sciences Inc. | 192.06 Thousand USD | -593440.628% |
Mainz Biomed B.V. | 2.19 Million USD | -51813.644% |
Trinity Biotech plc | 54.65 Million USD | -1985.901% |
Neuronetics, Inc. | 59.28 Million USD | -1822.922% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -101822.093% |